Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Procopio

Showing results (21-30 of 289) with videos related to

Pageof 29
Sort By:
Clinical and Experimental Nephrology|January 27, 2012
Is there a role for targeted therapies in the collecting ducts of Bellini carcinoma? Efficacy data from a retrospective analysis of 7 casesGiuseppe Procopio, Elena Verzoni, Roberto Iacovelli, et al.
Journal of Chromatography. A|July 7, 2025
Turning a micromixer into a separation column: The role of minimal surfaces and transversal transport in enhancing the performance of micro/nano Liquid ChromatographyValentina Biagioni, Giuseppe Procopio, Lorenzo Agosta, et al.
Expert Review of Anticancer Therapy|November 5, 2011
Targeted therapies used sequentially in metastatic renal cell cancer: overall results from a large experienceGiuseppe Procopio, Elena Verzoni, Roberto Iacovelli, et al.
Therapeutic Advances in Urology|October 4, 2016
Nivolumab in the treatment of advanced renal cell carcinoma: clinical trial evidence and experienceAlessia Mennitto, Paolo Grassi, Raffaele Ratta, et al.
Expert Review of Clinical Pharmacology|September 29, 2017
Multimodal treatment of advanced renal cancer in 2017Alessia Mennitto, Elena Verzoni, Paolo Grassi, et al.
Journal of Kidney Cancer and VHL|April 30, 2026
When Effective Therapies Collide: Aorto-Esophageal Fistula After Thoracic Radiotherapy and Anti-VEGF TKI in a Long-Survivor with mRCCSimone Rota, Valentina Guadalupi, Camilla Damonte, et al.
Expert Review of Anticancer Therapy|November 28, 2012
Primary resistance to tyrosine kinase inhibitors in patients with advanced renal cell carcinoma: state-of-the-scienceCamillo Porta, Roberto Sabbatini, Giuseppe Procopio, et al.
Rare Tumors|January 9, 2015
Response to targeted therapy in urachal adenocarcinomaIsabella Testa, Elena Verzoni, Paolo Grassi, et al.
Expert Review of Anticancer Therapy|October 4, 2012
Optimizing further treatment choices in short- and long-term responders to first-line therapy for patients with advanced renal cell carcinomaGiuseppe Procopio, Roberto Sabbatini, Camillo Porta, et al.
Expert Review of Anticancer Therapy|November 6, 2003
Update on the treatment of neuroendocrine tumorsEmilio Bajetta, Giuseppe Procopio, Leonardo Ferrari, et al.
Pageof 29

Showing results (21-30 of 289) with videos related to

Sort By:
Pageof 29
Clinical and Experimental Nephrology|January 27, 2012
Is there a role for targeted therapies in the collecting ducts of Bellini carcinoma? Efficacy data from a retrospective analysis of 7 casesGiuseppe Procopio, Elena Verzoni, Roberto Iacovelli, et al.
Journal of Chromatography. A|July 7, 2025
Turning a micromixer into a separation column: The role of minimal surfaces and transversal transport in enhancing the performance of micro/nano Liquid ChromatographyValentina Biagioni, Giuseppe Procopio, Lorenzo Agosta, et al.
Expert Review of Anticancer Therapy|November 5, 2011
Targeted therapies used sequentially in metastatic renal cell cancer: overall results from a large experienceGiuseppe Procopio, Elena Verzoni, Roberto Iacovelli, et al.
Therapeutic Advances in Urology|October 4, 2016
Nivolumab in the treatment of advanced renal cell carcinoma: clinical trial evidence and experienceAlessia Mennitto, Paolo Grassi, Raffaele Ratta, et al.
Expert Review of Clinical Pharmacology|September 29, 2017
Multimodal treatment of advanced renal cancer in 2017Alessia Mennitto, Elena Verzoni, Paolo Grassi, et al.
Journal of Kidney Cancer and VHL|April 30, 2026
When Effective Therapies Collide: Aorto-Esophageal Fistula After Thoracic Radiotherapy and Anti-VEGF TKI in a Long-Survivor with mRCCSimone Rota, Valentina Guadalupi, Camilla Damonte, et al.
Expert Review of Anticancer Therapy|November 28, 2012
Primary resistance to tyrosine kinase inhibitors in patients with advanced renal cell carcinoma: state-of-the-scienceCamillo Porta, Roberto Sabbatini, Giuseppe Procopio, et al.
Rare Tumors|January 9, 2015
Response to targeted therapy in urachal adenocarcinomaIsabella Testa, Elena Verzoni, Paolo Grassi, et al.
Expert Review of Anticancer Therapy|October 4, 2012
Optimizing further treatment choices in short- and long-term responders to first-line therapy for patients with advanced renal cell carcinomaGiuseppe Procopio, Roberto Sabbatini, Camillo Porta, et al.
Expert Review of Anticancer Therapy|November 6, 2003
Update on the treatment of neuroendocrine tumorsEmilio Bajetta, Giuseppe Procopio, Leonardo Ferrari, et al.
Pageof 29